S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Arnold, Vincent ^a,b   Cummings, Jean Saville ^a,c   Moreno Nieves, Uriel Y ^a   Didier, Céline ^a   Gilbert, Adrien ^a   Barré Sinoussi, Françoise ^a   Scott Algara, Daniel ^a  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

CD85j receptor; HIV 1; Ligand; NK cells; S100A9 protein

Indexed keywords

CALGRANULIN B; CD85J RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL FUNCTION; CELL STIMULATION; CELL SURFACE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION CONTROL; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD; CALGRANULIN B; DENDRITIC CELLS; HIV-1; HUMANS; KILLER CELLS, NATURAL; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECEPTORS, IMMUNOLOGIC; VIRUS REPLICATION;

EID: 84885969737     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-122     Document Type: Article

References (34)

1. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999, 17:875-904. 10.1146/annurev.immunol.17.1.875, 10358776.
2. Bellon T, Kitzig F, Sayos J, Lopez-Botet M. Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 2002, 168:3351-3359.
3. Saverino D, Fabbi M, Ghiotto F, Merlo A, Bruno S, Zarcone D, Tenca C, Tiso M, Santoro G, Anastasi G, et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol 2000, 165:3742-3755.
4. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997, 7:273-282. 10.1016/S1074-7613(00)80529-4, 9285411.
5. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997, 186:1809-1818. 10.1084/jem.186.11.1809, 2199153, 9382880.
6. Berg L, Riise GC, Cosman D, Bergstrom T, Olofsson S, Karre K, Carbone E. LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet 2003, 361:1099-1101. 10.1016/S0140-6736(03)12855-3, 12672315.
7. Kuroki K, Tsuchiya N, Shiroishi M, Rasubala L, Yamashita Y, Matsuta K, Fukazawa T, Kusaoi M, Murakami Y, Takiguchi M, et al. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum Mol Genet 2005, 14:2469-2480. 10.1093/hmg/ddi247, 16014635.
8. Monsivais-Urenda A, Nino-Moreno P, Abud-Mendoza C, Baranda L, Layseca-Espinosa E, Lopez-Botet M, Gonzalez-Amaro R. Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun 2007, 29:97-105. 10.1016/j.jaut.2007.05.003, 17601702.
9. Dietrich J, Cella M, Colonna M. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J Immunol 2001, 166:2514-2521.
10. Morel E, Bellon T. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j. J Immunol 2008, 181:2368-2381.
11. Saverino D, Merlo A, Bruno S, Pistoia V, Grossi CE, Ciccone E. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol 2002, 168:207-215.
12. Tenca C, Merlo A, Merck E, Bates EE, Saverino D, Simone R, Zarcone D, Trinchieri G, Grossi CE, Ciccone E. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J Immunol 2005, 174:6757-6763.
13. Lesport E, Baudhuin J, Sousa S, LeMaoult J, Zamborlini A, Rouas-Freiss N, Carosella ED, Favier B. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer. Cell Mol Life Sci 2011, 68:3385-3399. 10.1007/s00018-011-0632-7, 21337044.
14. Young NT, Waller EC, Patel R, Roghanian A, Austyn JM, Trowsdale J. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 2008, 111:3090-3096. 10.1182/blood-2007-05-089771, 18094328.
15. Kim JS, Choi SE, Yun IH, Kim JY, Ahn C, Kim SJ, Ha J, Hwang ES, Cha CY, Miyagawa S, Park CG. Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. Biochem Biophys Res Commun 2004, 315:144-150. 10.1016/j.bbrc.2004.01.027, 15013438.
16. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997, 386:514-517. 10.1038/386514a0, 9087413.
17. Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier LL. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 1998, 187:1681-1687. 10.1084/jem.187.10.1681, 2212284, 9584146.
18. Saverino D, Ghiotto F, Merlo A, Bruno S, Battini L, Occhino M, Maffei M, Tenca C, Pileri S, Baldi L, et al. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J Immunol 2004, 172:5629-5637.
19. Wagner CS, Riise GC, Bergstrom T, Karre K, Carbone E, Berg L. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J Immunol 2007, 178:3536-3543.
20. Scott-Algara D, Arnold V, Didier C, Kattan T, Pirozzi G, Barre-Sinoussi F, Pancino G. The CD85j + NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS One 2008, 3:e1975. 10.1371/journal.pone.0001975, 2276866, 18398485.
21. Urbinati C, Nicoli S, Giacca M, David G, Fiorentini S, Caruso A, Alfano M, Cassetta L, Presta M, Rusnati M. HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium. Blood 2009, 114:3335-3342. 10.1182/blood-2009-01-198945, 19661268.
22. Perera C, McNeil HP, Geczy CL. S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 2010, 88:41-49. 10.1038/icb.2009.88, 19935766.
23. Li C, Houser BL, Nicotra ML, Strominger JL. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci USA 2009, 106:5767-5772. 10.1073/pnas.0901173106, 2667005, 19304799.
24. Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, Cazaly A, Stathopoulos S, Middleton D, Mulder A, Claas FH, et al. Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci USA 2010, 107:10160-10165. 10.1073/pnas.0913745107, 2890497, 20439706.
25. Gebhardt C, Riehl A, Durchdewald M, Nemeth J, Furstenberger G, Muller-Decker K, Enk A, Arnold B, Bierhaus A, Nawroth PP, et al. RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 2008, 205:275-285. 10.1084/jem.20070679, 2271015, 18208974.
26. Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009, 86:557-566. 10.1189/jlb.1008647, 19451397.
27. Goebeler M, Roth J, Burwinkel F, Vollmer E, Bocker W, Sorg C. Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. Transplantation 1994, 58:355-361.
28. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut 1994, 35:669-674. 10.1136/gut.35.5.669, 1374754, 8200563.
29. Zwadlo G, Bruggen J, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 1988, 72:510-515. 1541584, 3048809.
30. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999, 10:661-671. 10.1016/S1074-7613(00)80065-5, 10403641.
31. Collins KL, Baltimore D. HIV's evasion of the cellular immune response. Immunol Rev 1999, 168:65-74. 10.1111/j.1600-065X.1999.tb01283.x, 10399065.
32. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008, 205:2235-2249. 10.1084/jem.20080132, 2556797, 18809714.
33. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004, 294:15-22. 10.1016/j.jim.2004.08.008, 15604012.
34. Piguet V, Schwartz O, Le Gall S, Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunol Rev 1999, 168:51-63. 10.1111/j.1600-065X.1999.tb01282.x, 10399064.